[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338997-105":59,"doc-detail-338997-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","shaping-immune-landscape-of-colorectal-cancer-by-cholesterol-metabolites-research","Shaping immune landscape of colorectal cancer by cholesterol metabolites - Research","","Cancer immunotherapies show major clinical success yet remain ineffective in a subset of tumors, including microsatellite-stable colorectal cancer (MSSCRC). This study defines a metabolic cue governing the distinct immune landscape of MSSCRC. Distal cholesterol precursors secreted by MSSCRC cells activate RORγt and polarize T cells toward Th17. Analyses of large human cohorts show asynchronous cholesterol biosynthesis drives precursor buildup, and inhibiting Cyp51 lowers precursors and suppresses tumor progression via Th17 modulation in preclinical models.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/shaping-immune-landscape-of-colorectal-cancer-by-cholesterol-metabolites-research/338997/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/shaping-immune-landscape-of-colorectal-cancer-by-cholesterol-metabolites-research/338997.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why focus on microsatellite-stable colorectal cancer (MSSCRC) in this study?","Question",{"text":113,"@type":114},"The document states that MSSCRC is largely insensitive to anti-PD-1 and/or anti-CTLA4 therapies, highlighting the need to study its immune landscape and identify new intervention strategies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What immune-cell change does MSSCRC cholesterol metabolism drive?",{"text":118,"@type":114},"The study reports that distal cholesterol precursors secreted by MSSCRC cells activate RORγt and polarize T cells toward Th17, which has pro-tumor functions in colorectal cancer.",{"name":120,"@type":111,"acceptedAnswer":121},"How does Cyp51 inhibition affect the tumor and the proposed mechanism?",{"text":122,"@type":114},"Pharmacological or genetic Cyp51 inhibition reduces intratumoral distal cholesterol precursors and suppresses tumor progression through a Th17-modulation mechanism in preclinical MSSCRC models.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338997,1790154668,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Article  \nShaping immune landscape of colorectal cancer by cholesterol metabolites  \nYibing Bai 1,10, Tongzhou Li2,10, Qinshu Wang3,10, Weiqiang You4,10, Haochen Yang 1, Xintian Xu5, Ziyi Li6, Yu Zhang1, Chengsong Yan1, Lei Yang1, Jiaqian Qiu2, Yuanhua Liu5, Shiyang Chen1,  \nDongfang Wang6, Binlu Huang1, Kexin Liu1, Bao- Liang Song 7, Zhuozhong Wang 8, Kang Li9, Xin Liu1, Guangchuan Wang 1, Weiwei Yang1, Jianfeng Chen1, Pei Hao5, Zemin Zhang6, Zhigang Wang4 ✉, Zheng-Jiang Zhu 2 ✉ & Chenqi Xu 1,3 ✉  \nAbstract  \nCancer immunotherapies have achieved unprecedented success in clinic, but they remain largely ineffective in some major types of cancer, such as colorectal cancer with microsatellite stability (MSSCRC) . It is therefore important to study tumor microenvironment of resistant cancers for developing new intervention strategies. In this study, we identify a metabolic cue that determines the unique immune landscape of MSS CRC. Through secretion of distal cholesterol precursors, which directly activate RORγt, MSS CRC cells can polarize T cells toward Th17 cells that have well-characterized pro-tumor functions in colorectal cancer. Analysis of large human cancer cohorts revealed an asynchronous pattern of the cholesterol biosynthesis in MSS CRC, which is responsible for the abnormal accumulation of distal cholesterol precursors. Inhibiting the cholesterol biosynthesis enzyme Cyp51, by pharmacological or genetic interventions, reduced the levels of intratumoral distal cholesterol precursors and suppressed tumor progression through a Th17-modulation mechanism in preclinical MSS CRC models. Our study therefore reveals a novel mechanism of cancer–immune interaction and an intervention strategy for the difﬁcult-to-treat MSS CRC.  \nKeywords Colorectal Cancer with Microsatellite Stability; Asynchronous Cholesterol Biosynthesis; Distal Cholesterol Precursors; Th17; Cyp51 Targeted Therapy  \nSubject Categories Cancer; Digestive System; Metabolism  \n[https://doi.org/10.1038/s44321-023-00015-9](https://doi.org/10.1038/s44321-023-00015-9)  \nReceived 1 November 2023; Revised 24 November 2023; Accepted 29 November 2023  \nPublished online: 2 January 2024  \nIntroduction  \nColorectal cancer (CRC) is one of the mostly diagnosed cancer types with high mortality rate (Dekker et al, 2019) . CRC can be categorized into subtypes with microsatellite stability (MSS; ~85% of patients) and microsatellite instability (MSI; ~15% of patients) . MSI CRC is one of the cancer types with best response rate to antiPD-1 immunotherapy (Lumish and Cercek, 2021) . MSS CRC, however, is insensitive to anti-PD-1 and/or anti-CTLA4 treatment, although MSS CRC has a comparable level of tumor mutational burden as anti-PD-1 responsive cancers (Picard et al, 2020; Yarchoan et al, 2017) . The poor performance of immunotherapies in MSS CRC reﬂects the urgent need of studying immune landscape of CRC subtypes.  \nAnalyzing CRC immune landscape by various technologies reveals enrichment of a pro-inﬂammatory CD4+ T cell subset Th17 in MSS CRC. In MSI CRC, another CD4+ T cell subset Th1 and cytotoxic CD8+ T cells are enriched (Le Gouvello et al, 2008; Lee et al, 2020; Mlecnik et al, 2016; Pelka et al, 2021; Zhang et al, 2018) . The anti-tumor functions of Th1 and CD8+ T cells have been well demonstrated, but the roles of Th17 in different types of cancer are context-dependent (Borst et al, 2018; Jiao et al, 2019; Palucka and Coussens, 2016; Zhao et al, 2020; Zou and Restifo, 2010) . Interleukin 17A (IL-17A), the major cytokine secreted by Th17, is known to promote CRC progression via both immune and cancer modulation mechanisms (Hurtado et al, 2018; Razi et al, 2019; Tosolini et al, 2011) . High IL-17A level is associated with poor prognosis in CRC, and ablation of IL-17A can prevent CRC metastasis (Tseng et al, 2014) . Moreover, IL-17 mediates PD-1 resistance in multiple cancer types by recruiting neutrophils (Akbay et al, 2017; Llosa et al, 2019; Zhang et al, 2020b) . Therefore, it","cbCaisYKhubPYeIq","https://ap.wps.com/l/cbCaisYKhubPYeIq","pdf",18056286,27,"English","# Abstract\n# Introduction\n# Results\n## MSS CRC cells polarize Th17 cells via a lipid cue","[{\"question\":\"Why focus on microsatellite-stable colorectal cancer (MSSCRC) in this study?\",\"answer\":\"The document states that MSSCRC is largely insensitive to anti-PD-1 and/or anti-CTLA4 therapies, highlighting the need to study its immune landscape and identify new intervention strategies.\"},{\"question\":\"What immune-cell change does MSSCRC cholesterol metabolism drive?\",\"answer\":\"The study reports that distal cholesterol precursors secreted by MSSCRC cells activate RORγt and polarize T cells toward Th17, which has pro-tumor functions in colorectal cancer.\"},{\"question\":\"How does Cyp51 inhibition affect the tumor and the proposed mechanism?\",\"answer\":\"Pharmacological or genetic Cyp51 inhibition reduces intratumoral distal cholesterol precursors and suppresses tumor progression through a Th17-modulation mechanism in preclinical MSSCRC models.\"}]","Shaping immune landscape of colorectal cancer by cholesterol metabolites - Research | PDF",1790027159,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a1fe4f4ca286842fd6f7fd5c419d31f.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b374f3af392a271001d4b0ee384f2ce.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06bfc7c613f4abfa41572f46e09f32f3.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e71462d5ee9a8184613e8320b759c7c.webp",980,1301]